Bridging Finance Inc. Announces Appointment of New CEO

bridging_finance_incTORONTO, Dec. 15, 2016 /CNW/ – Bridging Finance Inc. (“Bridging” or the “Company”) today announced the appointment of David Sharpe as Chief Executive Officer (“CEO”) and Ultimate Designated Person (pending regulatory approval) of the Company, reporting to the Chair of Bridging’s Board of Directors (the “Bridging Board”). In the view of the Bridging Board, the Company is at a crucial stage in its growth as a leading provider of alternative financing solutions and Mr. Sharpe’s appointment is expected to result in a continued focus on expanding Bridging’s existing lending and asset management business.

Mr. Sharpe succeeds Dr. Natasha Sharpe who shall remain as Chief Investment Officer (“CIO”) of the Company. Dr. Sharpe will also retain her position on the Bridging Board.

“I look forward to continuing to lead the growth of the company.” said Mr. Sharpe. “It is imperative that Natasha focus solely on her CIO duties to ensure that we continue to have solid corporate performance through this growth phase and beyond”.

Mr. Sharpe has been a veteran of the financial services industry for over 20 years. Prior to his appointment as CEO, Mr. Sharpe served as President and Chief Operating Officer of the Company.

About Bridging Finance Inc.:

Bridging Finance is a privately held Canadian company providing middle-market North American companies with alternatives to the financing options offered by traditional lenders. Lending proceeds are used by companies to address short-term needs such as restructuring existing debt, providing working capital for growth, supporting inventory purchases and financing expenditures and acquisitions/buyouts.  Bridging Finance is the Sub-Advisor to the Sprott Bridging Income Fund LP.  Bridging Finance also offers portfolio management services for institutional and family office clients.

SOURCE Bridging Finance Inc.

For further information: Andrew Mushore, Chief Compliance Officer, Bridging Finance Inc., 77 King St W, Suite 2925, Toronto, ON, M5K 1K7, T: (416) 362-6252

Click here for the full article.